RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..3 of 3 - per page
Order by
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries. More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark. More
Displaying 1..3 of 3 - per page
Order by

Related Reports

Your selection

Therapeutic target
Cardiovascular del
Cardiovascular disorder (other) del
Development phase
Early Stage del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us